ABSTRACT
Aberrant inflammation and structural lung damage occurs early in life for people with cystic fibrosis (CF). Even in the era of CFTR modulators, anti-inflammatory therapy may still be needed to prevent establishment and lifelong consequences of bronchiectasis. In this study, we integrated transcriptome-wide single-cell RNA sequencing data, highly multiplexed surface protein expression, and functional pathway analysis to create a comprehensive paediatric lower airway atlas of 44 immune and epithelial cell populations in bronchoalveolar lavage (BAL). We then analysed this atlas to investigate inflammatory cell responses in children with CF to show widespread dysregulation of macrophage function in the preschool CF lung. This included alterations in pathways associated with SARS-COV and influenza responses, TNF/IFN signalling, cholesterol homeostasis, and pulmonary fibrosis that were further altered by the early development of bronchiectasis. We showed that the CFTR modulator ivacaftor restores some of these macrophage-related functional deficits and reduces expression of pathways associated with neutrophil infiltration, however the modulator lumacaftor/ivacaftor was not associated with any detectable change in transcriptional response. This work represents a comprehensive, multi-omic single-cell analysis of bronchoalveolar lavage from preschool children and the results inform the future development of anti-inflammatory therapy for children with CF.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The authors would like to acknowledge funding support from the Chan Zuckerberg Initiative Inflammation Network, National Health and Medical Research Council of Australia Synergy Grant 1183640, Investigator Grant to AO GNT1196256, Investigator Grant to JM GNT2026098, and a Vertex Mentored Research Innovation Award. S.S is supported by a clinician-scientist fellowship from the Melbourne Childrens Campus.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This study was reviewed and approved by Royal Childrens Hospital Research Ethics Committee (HREC number 25054). Written informed consent to participate in the studies was provided by the participants legal guardian or next of kin.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
Funding: The authors would like to acknowledge funding support from the Chan Zuckerberg Initiative (Inflammation Network), National Health and Medical Research Council of Australia Synergy Grant (1183640), Investigator Grant to AO (GNT1196256), Investigator Grant to JM (2023/GNT2026098), and a Vertex Mentored Research Innovation Award. S.S is supported by a clinician-scientist fellowship from the Melbourne Children’s Campus.
Conflict of interest: The authors have no conflicts of interest to declare
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.